Form D — Tinos Therapeutics, Inc.
0002088485-26-000001 · filed 2026-04-17
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,000,000
- Total sold
- $2,250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Tinos Therapeutics, Inc.
- CIK
- 2088485
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 700 MAIN STREET
CAMBRIDGE, MA 02139 - Phone
- 570-939-7415
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nikolaos Tapinos · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
David Karambizi · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Anastasios Polimenakos · DirectorCambridge, MA Find on LinkedIn ↗
View original on SEC EDGAR.